1[1]Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: A unifiled approach to underlying principles, techniques and diagnostic imaging guidance. AJR, 2000, 174:323
2[2]Christophi C, Winkworth A, Muralihdran V,et al. The treatment of malignancy by hyperthermia. Surg Oncol, 1999, 7:83
3[3]Bertone V, Barni S, Silvotti MG,et al. Hyperthermic effects on the human metastatic liver: A TEM study. Anticancer Res, 1997, 17:4713
4[4]Moroz P, Jones SK, Gray BN. Status of hyperthermia in the treatment of advanced liver cancer. J Surg Oncolo, 2001, 77:259
5[5]Brezovich IA, Meredith RF. Practical aspects of ferromagnetic thermoseed hyperthermia. Radiologic Clinics of North America, 1989, 27:589
6[6]Mitsumori M, Hiraoka M, Shibata T,et al. Targeted hyperthermia using dextran magnetite complex: A new treatment modality for liver tumors. Hepato-gastroenterol, 1996, 43:1431
7[7]Jones SK, Gray BN, Burton MA,et al. Evaluation of ferromagnetic materials for low-frequency hysteresis heating of tumors. Phys Med Biol, 1992, 37:293
8[8]Widder KJ, Senyei A, Rannay DF. In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres. Cancer Research, 1980, 40:3512
9[9]Kato T, Nemato R, Mori H,et al. Sustained release properties of microencapsulated mitomycin C with ethylcellulose infused into the renal artery of the dog. Cancer, 1980, 46:14
10[10]Moroz P, Jones SK, Winter J. Targeting liver tumors with hyperthermia: Ferromagnetic embolization in a rabbit liver tumor model. J Surg Oncol, 2001, 78:22
